2013 Fiscal Year Final Research Report
Novel function of sigma-1 receptor and therapeutics strategy for neurodegenerative disorders
Project/Area Number |
24659024
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Single-year Grants |
Research Field |
Biological pharmacy
|
Research Institution | Tohoku University |
Principal Investigator |
FUKUNAGA KOHJI 東北大学, 薬学研究科(研究院), 教授 (90136721)
|
Co-Investigator(Kenkyū-buntansha) |
SHIODA Norifumi 東北大学, 大学院薬学研究科, 助教 (00374950)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Keywords | 筋萎縮性側索硬化症 / シグマー1受容体 / ミトコンドリア障害 / 小胞体ストレス / メチルピルビン酸 / ALS治療薬 |
Research Abstract |
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder caused by motor neuron dysfunction. Recently, a E102Q mutation in the chaperone protein sigma-1 receptor (R) was discovered in familial ALS patients. Here, we address mechanisms underlying neurodegeneration caused by this mutation using overexpression analysis in neuro2A cells. Sigma-1R(E102Q) overexpression promoted its dissociation from the endoplasmic reticulum (ER) membrane and its cytoplasmic aggregation, and in turn impaired mitochondrial ATP production. Under ER stress condition, sigma-1R(E102Q) overexpression aggravated mitochondrial damage, thereby causing apoptosis. The enhancement of ATP production by methyl pyruvate treatment rescued mitochondrial damage induced by sigma-1R(E102Q) overexpression. Taken together, phenotypes observed in sigma-1R(E102Q)-overexpressing cells suggest that ATP supplementation by methyl pyruvate is potential therapeutic strategy to treat ALS caused by sigma-1R mutations.
|
-
-
[Journal Article] Nitrosative stress induces peroxiredoxin 1 ubiquitination during ischemic insult via E6AP activation in endothelial cells both in vitro and in vivo2014
Author(s)
Tao RR, Wang H, Hong LJ, Huang JY, Lu YM, Liao MH, Ye WF, Lu NN, Zhu DY, Huang Q, Fukunaga K, Lou YJ, Shoji I, Wilcox CS, Lai EY, Han F
-
Journal Title
Antioxid Redox Signal
Volume: (in press)
DOI
Peer Reviewed
-
-
[Journal Article] Melatonin reverses the decreases in hippocampal protein serine/threonine kinases observed in an animal model of autism2014
Author(s)
Tian Y, Yabuki Y, Moriguchi S, Fukunaga K, Mao PJ, Hong LJ, Lu YM, Wang R, Ahmed MM, Liao MH, Huang JY, Zhang RT, Zhou TY, Long S, Han F
-
Journal Title
J Pineal Res
Volume: 56(1)
Pages: 1-11
DOI
Peer Reviewed
-
-
[Journal Article] Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles2014
Author(s)
Lu YM, Huang JY, Wang H, Lou XF, Liao MH, Hong LJ, Tao RR, Ahmed MM, Shan CL, Wang XL, Fukunaga K, Du YZ, Han F
-
Journal Title
Biomaterials
Volume: 35(1)
Pages: 530-7
DOI
Peer Reviewed
-
-
-
[Journal Article] The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain2013
Author(s)
Huang JY, Lu YM, Wang H, Liu J, Liao MH, Hong LJ, Tao RR, Ahmed MM, Liu P, Liu SS, Fukunaga K, Du YZ, Han F
-
Journal Title
Biomaterials
Volume: 34(32)
Pages: 7960-70
DOI
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Influence of Maternal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Socioemotional Behaviors in Offspring Rats2013
Author(s)
Nguyen AT, Nishijo M, Hori E, Nguyen NM, Pham TT, Fukunaga K, Nakagawa H, Tran AH, Nishijo H
-
Journal Title
Environ Health Insights
Volume: 7
Pages: 1-14
DOI
Peer Reviewed
-
[Journal Article] The Disturbance of Hippocampal CaMKII/PKA/PKC Phosphorylation in Early Experimental Diabetes Mellitus2013
Author(s)
Liao MH, Xiang YC, Huang JY, Tao RR, Tian Y, Ye WF, Zhang GS, Lu YM, Ahmed MM, Liu ZR, Fukunaga K, Han F
-
Journal Title
CNS Neurosci Ther
Volume: 19(5)
Pages: 329-36
DOI
Peer Reviewed
-
-
-
[Journal Article] Theγ-secretase blocker DAPT reduces the permeability of the blood-brain barrier by decreasing the ubiquitination and degradation of occludin during permanent brain ischemia2013
Author(s)
Zhang GS, Tian Y, Huang JY, Tao RR, Liao MH, Lu YM, Ye WF, Wang R, Fukunaga K, Lou YJ, Han F
-
Journal Title
CNS Neurosci Ther
Volume: 19(1)
Pages: 53-60
DOI
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-